|
Age (year)
|
Mean
|
55.7
| |
| |
Range
|
9-95
| |
|
Sex
|
Male
|
38
|
(44.7%)
|
| |
Female
|
47
|
(55.3%)
|
|
Location
|
Upper extremity
|
14
|
(16.5%)
|
| |
Lower extremity
|
47
|
(55.3%)
|
| |
Trunk
|
24
|
(28.2%)
|
|
Extension
|
Intracompartmental
|
36
|
(42.4%)
|
| |
Extracompartmental
|
49
|
(57.6%)
|
|
Tumor size (mm)
|
Mean
|
87.0
| |
| |
Range
|
20-308
| |
|
Diagnosis
|
Bone
|
19
| |
| |
Osteosarcoma
|
10
|
(11.8%)
|
| |
Chondrosarcoma
|
8
|
(9.4%)
|
| |
Others
|
1
|
(1.2%)
|
| |
Soft tissue
|
67
| |
| |
Liposarcoma
|
23
|
(27.1%)
|
| |
Undifferentiated pleomorphic sarcoma
|
14
|
(16.5%)
|
| |
Leiomyosarcoma
|
7
|
(8.2%)
|
| |
Malignant peripheral nerve sheath tumor
|
5
|
(5.9%)
|
| |
Others
|
17
|
(20.0%)
|
|
Grade
|
High
|
48
|
(56.5%)
|
| |
Low
|
37
|
(43.5%)
|
|
Surgical margin
|
Adequate
|
74
|
(87.1%)
|
| |
Inadequate
|
11
|
(12.9%)
|
|
Follow up period (months)
|
Mean
|
23.0
| |
| |
Range
|
6-50
| |
